Building Future Leaders in Transfusion Medicine – TRAM Leadership Program
Transfusion Arena Mentorship (TRAM) Leadership Program shared a post on LinkedIn:
“TRAMonian Spotlight | TRANSCON 2026
What does it look like when a TRAMonian steps onto a national platform?
At TRANSCON 2026 by ISBTI, Ruchi Punamia represented the TRAM community through multiple academic and professional roles, bringing together scientific engagement, research, communication and academic contribution.
Scientific speaker
She delivered a talk on ‘Artificial Blood Development Programme – A Ray of Hope’, exploring an emerging and evolving area of research and innovation in Transfusion Medicine.
E-poster judge
Immunohematology
She also had the privilege of serving as a judge for the E-Poster Competition in the Immunohematology domain, engaging with young researchers, understanding their work and thought processes, and contributing to the academic evaluation of their research.
What makes this especially meaningful from a TRAM perspective is the breadth of these engagements.
TRAM is built around the belief that developing future Transfusion Medicine leaders goes beyond scientific knowledge alone.
It is about developing the ability to:
Think. Communicate. Present. Evaluate. Collaborate. Lead.
From exploring emerging scientific frontiers such as artificial blood development, to critically engaging with research as a poster judge – these are different dimensions of professional leadership coming together.
And this is precisely the kind of growth we hope to see within the TRAM community.
For us, a TRAMonian is not defined simply by having completed a programme.
It is someone who continues to learn, contribute and create opportunities for others within the profession.
Congratulations, Dr. Ruchi, on these wonderful contributions at TRANSCON 2026 and for representing the spirit of TRAM through curiosity, academic engagement and a willingness to step into diverse roles.
From learning through TRAM to contributing back to the Transfusion Medicine community — this is the journey we hope to nurture.”
Stay updated with Hemostasis Today.
-
Nov 10, 2026, 16:28Can the VWF to ADAMTS-13 Ratio Predict Mortality in Sepsis-Induced Coagulopathy? – RPTH Journal
-
Nov 10, 2026, 16:28Ruth Willems: PhD Defence at Maastricht University on Thrombosis and Bleeding in HPB Disease
-
Nov 10, 2026, 16:09Edward Lee Carter: Factor XIa Inhibition Enters Clinical Practice
-
Nov 10, 2026, 16:08Edward C.C. Wong: Deriving Ferritin Cutoffs for Iron Deficiency Using RBC Parameters
-
Nov 10, 2026, 16:07Milad Abdalla: Decoding Hemoglobin Electrophoresis – A Practical Diagnostic Reference
-
Nov 10, 2026, 15:13Wolfgang Miesbach: Nonviral Gene Therapy for Haemophilia A Using Lipid Nanoparticles
-
Nov 10, 2026, 15:06Dahra Teles: First Speaking Experience at HEMO 2026 on First-Line Multiple Myeloma Treatment
-
Nov 10, 2026, 14:55Yazan Abou-Ismail: First FDA-Approved Factor XIa Inhibitor for Stroke Prevention
-
Nov 10, 2026, 14:49Ifeanyichukwu Ifechidere: The Role of Coagulation in Anaesthesia and Surgery